Perfluoroalkyl Substance Exposure and the BDNF Pathway in the Placental Trophoblast

Front Endocrinol (Lausanne). 2021 Jul 28:12:694885. doi: 10.3389/fendo.2021.694885. eCollection 2021.

Abstract

Background: Per- and polyfluoroalkyl substances (PFAS) are persistent organic pollutants that have become globally ubiquitous in humans and the environment. In utero PFAS exposure is associated with neurodevelopmental effects; however, the mechanism is poorly understood. Brain-derived neurotrophic factor (BDNF) signaling is critical to fetal neurodevelopment during pregnancy and maintains important regulatory roles later in life. This study aims to characterize placental BDNF signaling and investigate whether PFAS exposure disrupts the signaling pathway in placental trophoblast cells.

Methods: The expression and localization of BDNF receptors-p75NTR and TrkB-in first trimester and term human placentas and trophoblast cells were investigated by immunofluorescence staining. To assess the effects of PFAS exposure on the BDNF pathway, BeWo cells were treated with PFAS mixtures that mimicked blood levels in a highly exposed population and major PFAS compounds in the mixture at 0.01, 0.1, 1, and 10 µM concentrations. Changes in pro-BDNF levels and phosphorylation of TrkB receptors were examined by Western blot.

Results: In first trimester human placentas, TrkB and p75NTR receptors were primarily localized to syncytiotrophoblast and cytotrophoblast cells. At term, TrkB and p75NTR receptors were primarily observed in the placental villous stroma. TrkB receptor staining in trophoblasts was reduced at term, while p75NTR receptor staining was negative. TrkB receptors were confined to the nuclear and perinuclear spaces, and phosphorylation occurred at the Tyr816 residue in BeWo cells. Exposure to PFOS, PFOA, PFBS, and the six-PFAS mixture did not significantly affect BDNF levels or activation (phosphorylation) of TrkB. Treating cells with 1 μM and 10 μM of PFNA resulted in increased TrkB phosphorylation compared to unexposed controls, but BDNF levels were unchanged.

Conclusions: BDNF receptors are present in different regions of human placental villi, indicating diverse functions of BDNF signaling in placental development. Our findings suggest that the BDNF pathway in placental trophoblast cells is not disrupted by exposures to PFOS, PFOA, PFBS, and a PFAS mixture, but may be affected by PFNA exposures. Further investigation is needed on how PFAS affects other critical signaling pathways during fetal neurodevelopment.

Keywords: BDNF; Perfluoroalkyl substances; TrkB; placenta; trophoblast.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Brain-Derived Neurotrophic Factor / metabolism*
  • Female
  • Fluorocarbons / toxicity*
  • Humans
  • Maternal Exposure / adverse effects
  • Membrane Glycoproteins / metabolism
  • Phosphorylation
  • Placenta / drug effects
  • Placenta / metabolism
  • Placentation / drug effects
  • Pregnancy
  • Pregnancy Trimester, First / drug effects
  • Pregnancy Trimester, First / metabolism
  • Receptor, trkB / metabolism
  • Signal Transduction / drug effects
  • Trophoblasts / drug effects*
  • Trophoblasts / metabolism
  • Tumor Cells, Cultured

Substances

  • Brain-Derived Neurotrophic Factor
  • Fluorocarbons
  • Membrane Glycoproteins
  • BDNF protein, human
  • Receptor, trkB
  • tropomyosin-related kinase-B, human